objective basis to specific investors (Private Placement) for purpose of increasing the liquidity and supporting the expansion of the Company’s core business, as well as investing in various projects; and the
the base price for sale of shares in each subsidiary at the price with a discount not exceeding 10 percent of the valuation of investment monies recommended by the financial advisor from KT Zmico
supporting the expansion of the Company’s core business, as well as investing in various projects; and the amendment of Clause 4 of the Memorandum of Association to be in line with the capital increase. The
Meeting regarding no payment of dividend, schedule of Annual General Meeting of Shareholder for the year 2019, capital increase by allocating via general mandate, an increasing of investment cost in
opportunities for investment in power projects both domestic and overseas. Currently, the Tender Offer’s core business is the production and distribution of public utilities, whereby the Tender Offeror is both
% of paid up capital, Total investment 50 Millions baht. The acquisition of BS Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. The Company signed the share
of dividend, schedule of Annual General Meeting of Shareholder for the year 2019, capital increase by allocating via general mandate, an increasing of investment cost in Carnival Magic Project, and
the Company, i.e. university business. After the disposal of its investment in NU, the Company would proceed with its strategies and policies to engage in the core business of media and content, in